Important Recall: 3 more heartburn meds are off the market

This is your medical minute report of the week. According to at least 3 companies and U.S regulators, the following medications meant to treat heartburn have been recalled from the market.

Appco Pharma and Denton Pharma and Mylan are the three companies responsible for pulling their products. According to the FDA, those products include two generic forms of Zantac which have been found to contain the carcinogenic traces of NDMA. The generic forms of this medication may otherwise be known as ranitidine (Mylan’s is Nizatidine.)

The problem? The FDA says that they’ve found NDMA – the short-hand for N-Nitrosodimethylamine –  in all of the drugs listed. They’ve found traces of said carcinogen well beyond legal levels in the U.S. NDMA is and has been proven to be a carcinogenic agent in multiple animal species and is known to cause liver; lung, and multiple other forms of cancer.